Comparative studies of inhaled corticosteroids in asthma

European Respiratory Journal

Volumn 17, Issue 4, 2001, Pages 579-580

  Beasley, R ^a   Sterk, P J ^a   Kerstjens, H A M ^a   Decramer, M ^a  

^a UNIVERSITY OF OTAGO   (New Zealand)

Author keywords

[No Author keywords available]

Indexed keywords

BECLOMETASONE DIPROPIONATE; BUDESONIDE; CORTICOSTEROID; FLUTICASONE;

ADRENAL FUNCTION; ANTIINFLAMMATORY ACTIVITY; ARTICLE; ASTHMA; CLINICAL STUDY; COMPARATIVE STUDY; CONTROLLED STUDY; DOSE RESPONSE; DRUG COMBINATION; DRUG COMPARISON; DRUG DELIVERY SYSTEM; DRUG EFFICACY; DRUG MECHANISM; DRUG SAFETY; HUMAN; INHALER; LONG TERM CARE; METHODOLOGY; POLICY; PRIORITY JOURNAL; PUBLICATION; RISK BENEFIT ANALYSIS; SELF CARE;

ADMINISTRATION, INHALATION; ADRENAL CORTEX HORMONES; ASTHMA; HUMANS;

EID: 0035007111     PISSN: 09031936     EISSN: None     Source Type: Journal    
DOI: 10.1183/09031936.01.17405790     Document Type: Article

References (29)

1. Aerosol beclomethasone dipropionate: A dose-response study in chronic bronchial asthma
2. Comparison of oral steroid sparing by high dose and low dose inhaled steroid in maintenance treatment of severe asthma
3. Efficacy response of inhaled beclomethasone dipropionate in asthma is proportional to dose and is improved by formulation with a new propellant
4. A double-blind dose-response study of budesonide by inhalation in patients with bronchial asthma
5. Budesonide delivered by Turbuhaler is effective in a dose-dependent fashion when used in the treatment of adult patients with chronic asthma
6. Dose-related efficacy of budesonide administered via a dry powder inhaler in the treatment of children with moderate to severe persistent asthma
7. Fluticasone propionate aerosol for the treatment of adults with mild to moderate asthma: The fluticasone propionate asthma study group
8. Effectiveness of fluticasone propionate in patients with moderate asthma: A dose-ranging study
9. Low-and high-dose fluticasone propionate in asthma; effects during and after treatment
10. Efficacy and safety of inhaled corticosteroids: New developments
11. A dose-ranging study of fluticasone propionate in adult patients with moderate asthma
12. A randomized, double-blind dose reduction study to compare the minimal effective dose of budesonide Turbuhaler and fluticasone propionate Diskhaler
13. Dose-response of inhaled drugs in asthma: An update
14. Effects of reducing or discontinuing inhaled budesonide in patients with mild asthma
15. Effect of early versus late intervention with inhaled corticosteroids in asthma
16. Starting with a higher dose of inhaled corticosteroid in primary care asthma treatment
17. Effect of inhaled fluticasone propionate on airway responsiveness in treatment-naive individuals: A lesser benefit in females
18. Pulmicort Turbohaler once daily as initial prophylactic therapy for asthma
19. Comparative safety and efficacy of single or twice daily administration of inhaled beclomethasone in moderate asthma
20. Effect of inhaled formoterol and budesonide on exacerbations of asthma
21. Lose-dose inhaled fluticasone propionate versus oral zafirlukast in the treatment of persistent asthma
22. Salmeterol and fluticasone propionate (50/250 microg) administered via combination Diskus inhaler: As effective as when given via separate Diskus inhalers
23. Combined salmeterol 50 μg and fluticasone propionate 250 μg in the Diskus device for the treatment of asthma
24. Randomised comparison of guided self-management and traditional treatment of asthma over one year
25. Clinical control and histopathologic outcome of asthma when using airway hyperresponsiveness as an additional guide to long-term treatment
26. Dose-response evaluation of the therapeutic index for inhaled budesonide in patients with mild to moderate asthma
27. Inhaled beclomethasone dipropionate down-regulates airway lymphocyte activation in atopic asthma
28. 2-agonist, terbutaline, on airway inflammation in newly diagnosed asthma: A randomized, double-blind, parallel-group controlled trial
29. Inhaled corticosteroid use and bone-mineral density in patients with asthma